Sustained virologic response after eight weeks of treatment with sofosbuvir, ledipasvir, and ribavirin in a decompensated cirrhotic patient with hepatitis C virus genotype 1b.

导出 LinkOut

翻译打印收藏纠错

第一作者： Ohki,Taniyama

第一单位： Digestive and Lifestyle Diseases, Department of Human and Environmental Sciences, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.

作者： Ohki,Taniyama ^[1] ; Seiichi,Mawatari ^[2] ; Kohei,Oda ^[1] ; Kazuaki,Tabu ^[1] ; Sho,Ijuin ^[1] ; Kotaro,Kumagai ^[1] ; Ai,Kasai ^[1] ; Shuzo,Tashima ^[1] ; Tsutomu,Tamai ^[1] ; Akihiro,Moriuchi ^[1] ; Akio,Ido ^[2]

作者单位： Digestive and Lifestyle Diseases, Department of Human and Environmental Sciences, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan. ^[1] Department of Gastroenterology and Hepatology, Kagoshima City Hospital, Kagoshima, Japan. ^[2]

关键词 LDV SOF decompensated cirrhosis

DOI 10.1111/hepr.13235

PMID 30048035

发布时间 2020-10-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览6

Hepatology research

2019年49卷2期

239-243页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Sustained virologic response after eight weeks of treatment with sofosbuvir, ledipasvir, and ribavirin in a decompensated cirrhotic patient with hepatitis C virus genotype 1b.

Hepatology research

相似文献

Hepatology research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Sustained virologic response after eight weeks of treatment with sofosbuvir, ledipasvir, and ribavirin in a decompensated cirrhotic patient with hepatitis C virus genotype 1b.

Hepatology research

相似文献

Hepatology research

相关期刊

检索历史清除